株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

先進義肢/装具・外骨格 (エクソスケルトン) の世界市場 - 分析と予測:用途・対象義肢・エンドユーザー・競合情勢 (2019-2024年)

Global Advanced Prosthetics and Exoskeletons Market: Focus on Application, Targeted Limb, End-User, Competitive Landscape - Analysis and Forecast, 2019-2024

発行 BIS Research Inc. 商品コード 913750
出版日 ページ情報 英文 176 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
先進義肢/装具・外骨格 (エクソスケルトン) の世界市場 - 分析と予測:用途・対象義肢・エンドユーザー・競合情勢 (2019-2024年) Global Advanced Prosthetics and Exoskeletons Market: Focus on Application, Targeted Limb, End-User, Competitive Landscape - Analysis and Forecast, 2019-2024
出版日: 2019年09月30日 ページ情報: 英文 176 Pages
概要

世界の先進義肢/装具・外骨格 (エクソスケルトン) 市場規模は、2018年の21億1,000万米ドルから、2024年までに38億2,000万米ドルへ達すると推計され、2019年から2024年にかけては10.42%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界の先進義肢/装具・外骨格 (エクソスケルトン) 市場について調査分析し、市場力学、競合情勢、産業分析、セグメント別の市場分析と予測、地域別分析、主要企業について、体系的な情報を提供しています。

913750_Figure 1 Advanced Prosthetics and Exoskeletons Market (2019- 2024)

エグゼクティブサマリー

第1章 製品定義

第2章 調査範囲

第3章 調査手法

第4章 競合情勢

第5章 市場概要

  • 義肢/装具・外骨格型技術の登場
  • 先進義肢/装具・外骨格市場の分類
  • 新興技術
  • 市場ダイナミクスの概要
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場課題

第6章 先進義肢/装具・外骨格市場:用途別

  • 市場概要
  • 義肢/装具
  • 矯正用外骨格

第7章 先進義肢/装具・外骨格市場:四肢タイプ別

  • 市場概要
  • 下肢セグメント
  • 上肢セグメント
  • 全身セグメント

第8章 先進義肢/装具・外骨格市場:エンドユーザー別

  • 市場概要
  • 矯正・義肢/装具クリニック
  • 病院

第9章 先進義肢/装具・外骨格市場:地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第10章 企業プロファイル

  • AlterG, Inc.
  • Bionik Laboratories Corp.
  • Breg, Inc
  • Bauerfeind AG
  • Blatchford Group
  • Cyberdyne, Inc.
  • DJO Global Inc.
  • DeRoyal Industries, Inc
  • Ekso Bionics Holdings, Inc.
  • Ossur hf.
  • Ottobock SE & Co. KGaA.
  • Mobius Bionics
  • ReWalk Robotics, Inc.
  • Rex Bionics
  • Willow Wood Global LLC.
図表

List of Tables

  • Table 1: Number of Road Accidents and Prevalence of Diabetes (Year - 2017/2018)
  • Table 2: Impact of Market Drivers, 2018-2029
  • Table 3: Impact of Market Restraints, 2018-2029
  • Table 4.1: Regulatory Bodies Related to Prosthetics and Exoskeletons (by Country)
  • Table 5.1: Total number of Diabetics in 2018 and 2024 (Country Wise)
  • Table 5.2: Impact of Market Drivers, 2018-2029
  • Table 5.3: Impact of Market Restraints, 2018-2029

List of Figures

  • Figure 1: Advanced Prosthetics and Exoskeletons Market (2019- 2024)
  • Figure 2: Advanced Prosthetics and Exoskeletons Market, (by Application), 2018 and 2024
  • Figure 3: Advanced Prosthetics and Exoskeletons Market, (by Limb Type), 2018 and 2024
  • Figure 4: Advanced Prosthetics and Exoskeletons Market (by End User), 2018 and 2024
  • Figure 5: Advanced Prosthetics and Exoskeletons Market (by Region), 2018 and 2024
  • Figure 6: Percent Share of Key Developments and Strategies (January-2016 to August -2019)
  • Figure 7: Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market, By Prosthetic Players
  • Figure 8: Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market, by Orthotic Exoskeleton Players
  • Figure 9: Overall Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market
  • Figure 2.1: Advanced Prosthetics and Exoskeletons Market
  • Figure 3.1: Advanced Prosthetics and Exoskeletons Market: Research Methodology
  • Figure 3.2: Secondary Research
  • Figure 3.3: Data Triangulation
  • Figure 3.4: Bottom-Up Approach
  • Figure 3.5: Top-Down Approach
  • Figure 3.6: Considered Factors for Data Prediction and Modelling
  • Figure 4.1: Percent Share of Key Developments and Strategies (January-2016 to August -2019)
  • Figure 4.2: Percentage Share of Strategic Developments by Leading Companies in the Advanced Prosthetics and Exoskeletons Market, 2016-2019
  • Figure 4.3: Percentage of Product Launches and Product Approvals (By Company)
  • Figure 4.4: Percent Share of Strategic Agreements by Key Players (January 2016 to August 2019)
  • Figure 4.5: Percent Share of Mergers and Acquisitions by Key players (January 2016- August-2019)
  • Figure 4.6: Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market, By Prosthetic Players
  • Figure 4.7: Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market, By Orthotic Exoskeleton Players
  • Figure 4.8: Overall Market Share Analysis for the Advanced Prosthetics and Exoskeletons Market
  • Figure 5.1: Advanced Prosthetics and Exoskeletons Market (2019-2024)
  • Figure 5.2: Percentage of World Population in the Age Group of 65 Years and Above, 2010-2017
  • Figure 6.1: Advanced Prosthetics and Exoskeletons Market (By Application)
  • Figure 6.2: Advanced Prosthetics and Exoskeletons Market by Prosthetics, $Million, 2018-2024
  • Figure 6.3: Advanced Prosthetics Market by Sub-Segments
  • Figure 6.4: Advanced Prosthetics and Exoskeletons Market by Functional Prosthesis Application of Prosthetic Segment, $Million, 2018-2024
  • Figure 6.5: Advanced Prosthetics and Exoskeletons Market by Cosmesis Realistic Application of Prosthetic Segment, $Million, 2019-2024
  • Figure 6.6: Advanced Prosthetics and Exoskeletons Market by Orthotic Exoskeleton, $Million, 2018-2024
  • Figure 6.7: Advanced Prosthetics and Exoskeletons Market (by Orthotic Exoskeleton)
  • Figure 6.8: Advanced Prosthetics and Exoskeletons Market, by Support Application of Orthotic Exoskeleton Segment, $Million, 2018-2024
  • Figure 6.9: Advanced Prosthetics and Exoskeletons Market, by Rehabilitation Application of Orthotic Exoskeleton segment, $Million, 2018-2024
  • Figure 7.1: Advanced Prosthetics and Exoskeletons Market Segment by Limb Type
  • Figure 7.2: Advanced Prosthetics and Exoskeletons Market by Lower Limb Type, $Million, 2019-2024
  • Figure 7.3: Advanced Prosthetics and Exoskeletons Market Sub-Segment by Lower Limb Type, Billion, 2019 and 2024
  • Figure 7.4: Advanced Prosthetics and Exoskeletons Market, by Transtibial Type of Lower Limb Segment, $Million, 2018-2024
  • Figure 7.5: Advanced Prosthetics and Exoskeletons Market, By Transfemoral Type of Lower Limb Segment, $Million, 2018-2024
  • Figure 7.6: Advanced Prosthetics and Exoskeletons Market by Upper Limb Type, $Million, 2018-2024
  • Figure 7.7: Advanced Prosthetics and Exoskeletons Market Sub-Segment (By Upper Limb Type), Million, 2018 and 2024
  • Figure 7.8: Advanced Prosthetics and Exoskeletons Market (By Trans-radial Type of Upper Limb Segment), $Million, 2018-2024
  • Figure 7.9: Advanced Prosthetics and Exoskeletons Market (By Transhumeral Type of Lower Limb Segment), $Million, 2018-2024
  • Figure 7.10: Advanced Prosthetics and Exoskeletons Market (By Full Body Type), $Million, 2019-2024
  • Figure 8.1: Advanced Prosthetics and Exoskeletons Market Sub-Segment (By End User), Billion, 2018 and 2024
  • Figure 8.2: Advanced Prosthetics and Exoskeletons Market by Orthotic and Prosthetic Clinic, $Million, 2019-2023
  • Figure 8.3: Advanced Prosthetics and Exoskeletons Market by Hospitals, $Billion, 2019-2024
  • Figure 9.1: Advanced Prosthetics and Exoskeletons Market (by Region), 2018-2024, $Billion
  • Figure 9.2: Advanced Prosthetics and Exoskeletons Market Sub-Segment by Region, Billion, 2018 and 2024
  • Figure 9.3: North America Advanced Prosthetics and Exoskeletons Market by North America, 2018-2024
  • Figure 9.4: North America Advanced Prosthetics and Exoskeletons Market Scenario by Application, 2018 and 2024, $Billion
  • Figure 9.5: North America Advanced Prosthetics and Exoskeletons Market Scenario by Limb Type, 2018 and 2024, $Billion
  • Figure 9.6: North America Advanced Prosthetics and Exoskeletons Market Scenario, by End User, 2018 and 2024, $Billion
  • Figure 9.7: U.S. Advanced Prosthetics and Exoskeletons Market, 2018-2024, $Billion
  • Figure 9.8: Canada Advanced Prosthetics and Exoskeletons Market, 2018-2024, $Billion
  • Figure 9.9: Europe Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.10: Europe Advanced Prosthetics and Exoskeletons Market Scenario by Application, 2018 and 2024, $Billion
  • Figure 9.11: Europe Advanced Prosthetics and Exoskeletons Market Scenario by Limb Type, 2018 and 2024, $Billion
  • Figure 9.12: Europe Advanced Prosthetics and Exoskeletons Market Scenario by Limb Type, 2018 and 2024, $Billion
  • Figure 9.13: Germany Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.14: U.K. Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.15: Spain Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.16: France Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.17: Rest-of-Europe Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.18: Asia- Pacific Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.19: Asia-Pacific Advanced Prosthetics and Exoskeletons Market Scenario by Application, 2018 and 2024, $Billion
  • Figure 9.20: Asia-Pacific Advanced Prosthetics and Exoskeletons Market Scenario by Limb Type, 2018 and 2024, $Billion
  • Figure 9.21: Asia-Pacific Advanced Prosthetics and Exoskeletons Market Scenario by End User Type, 2018 and 2024, $Billion
  • Figure 9.22: China Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.23: Japan Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.24: India Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.25: South Korea Advanced Prosthetics and Exoskeletons Market 2018-2024
  • Figure 9.26: Rest-of-Asia-Pacific Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.27: Rest-of-the-World Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.28: LATAM Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 9.29: MEA Advanced Prosthetics and Exoskeletons Market, 2018-2024
  • Figure 10.1: Share of Key Company Profiles
  • Figure 10.2: Alter G, Inc.: Product Portfolio
  • Figure 10.3: Alter G.: SWOT Analysis
  • Figure 10.4: Bionik Laboratories: Product Portfolio
  • Figure 10.5: Bionik Laboratories Corp.: Overall Financials, 2016-2018
  • Figure 10.6: Bionik Laboratories Corp.: R&D Expenditure, 2016-2018
  • Figure 10.7: Bionik Laboratories Corp.: SWOT Analysis
  • Figure 10.8: Breg, Inc.: Overall Product Portfolio
  • Figure 10.9: Breg, Inc.: SWOT Analysis
  • Figure 10.10: Bauerfeind AG.: Overall Product Portfolio
  • Figure 10.11: Bauerfeind AG.: SWOT Analysis
  • Figure 10.12: Blatchford Group: Overall Product Portfolio
  • Figure 10.13: Blatchford Group: SWOT Analysis
  • Figure 10.14: Cyberdyne Inc.: Overall Product Portfolio
  • Figure 10.15: Cyberdyne, Inc.: Overall Financials, 2015-2017
  • Figure 10.16: Cyberdyne, Inc.: SWOT Analysis
  • Figure 10.17: DJO Global Inc..: Overall Financials, 2015-2017
  • Figure 10.18: DJO Global Inc. Net Revenue (by Business Segment), 2015-2017
  • Figure 10.19: DJO Global Inc. Net Revenue (by Region), 2015-2017
  • Figure 10.20: DJO Global Inc.: R&D Expense, 2015-2017
  • Figure 10.21: DJO Global Inc.: SWOT Analysis
  • Figure 10.22: DeRoyal Industries.: Overall Product Portfolio
  • Figure 10.23: DeRoyal Industries: SWOT Analysis
  • Figure 10.24: Ekso Bionics Holdings, Inc.: Overall Product Portfolio
  • Figure 10.25: Ekso Bionics Holdings, Inc.: Overall Financials, 2016-2018
  • Figure 10.26: Ekso Bionics Holdings, Inc. Net Revenue (by Business Segment), 2016-2018
  • Figure 10.27: Ekso Bionics Holdings, Inc. Net Revenue (by Region), 2016-2018
  • Figure 10.28: Ekso Bionics Holdings, Inc.: R&D Expense, 2016-2018
  • Figure 10.29: Ekso Bionics Holdings, Inc.: SWOT Analysis
  • Figure 10.30: Ossur Corporate: Overall Product Portfolio
  • Figure 10.31: Ossur Corporate: Overall Financials, 2016-2018
  • Figure 10.32: Ossur Corporate Net Revenue (by Business Segment), 2016-2018
  • Figure 10.33: Ossur Corporate: Net Revenue (by Region), 2016-2018
  • Figure 10.34: Ossur Corporate: R&D Expense, 2016-2018
  • Figure 10.35: Ossur Corporate: SWOT Analysis
  • Figure 10.36: Ottobock SE & Co. KGA: Overall Product Portfolio
  • Figure 10.37: Ottobock SE & Co. KGA: SWOT Analysis
  • Figure 10.38: Mobius Bionics: Overall Product Portfolio
  • Figure 10.39: Mobius Bionics: SWOT Analysis
  • Figure 10.40: ReWalk Robotics.: Overall Product Portfolio
  • Figure 10.41: ReWalk Robotics, Inc. Overall Financials, 2016-2018
  • Figure 10.42: ReWalk Robotics, Inc. Net Revenue (by Region), 2016-2018
  • Figure 10.43: ReWalk Robotics, Inc.: R&D Expenditure, 2016-2018
  • Figure 10.44: ReWalk: SWOT Analysis
  • Figure 10.45: Rex Bionics: Overall Product Portfolio
  • Figure 10.46: Rex Bionics PLC.: Overall Financials, 2015-2017
  • Figure 10.47: Rex Bionics: SWOT Analysis
  • Figure 10.48: Willow Wood: Overall Product Portfolio
  • Figure 10.49: Willow Wood LLC: SWOT Analysis
目次
Product Code: BH162A

"Global Advanced Prosthetics and Exoskeletons Market to Reach $3.82 Billion by 2024."

Key Questions Answered in this Report:

  • How big is the advanced prosthetics and exoskeletons market and what are its future estimates?
  • What are the drivers, restraints, and opportunities of this market?
  • What are the emerging technologies in the advanced prosthetics and exoskeletons market?
  • What will be the growth of sub-segments of the advanced prosthetics and exoskeletons market?
  • What are the applications of the products offered by the companies in advanced prosthetics and exoskeletons market?
  • How will the advanced prosthetics and exoskeletons market segments behave in different regions, and countries? What are the expected growth rates?
  • What are the key developments in this market- mergers and acquisitions, product launches in the past four years?
  • Who are the dominant players in this advanced prosthetics and exoskeletons market?

Advanced Prosthetics and Exoskeletons Market Forecast, 2019-2024

The advanced prosthetics and exoskeletons market was valued to be $2.11 Billion in 2018 and is estimated to reach a market value of $3.82 Billion by 2024 at a CAGR of 10.42% from 2019 to 2024.

The market is subjected to the pace of technological advancement and the rising demand by the governments to reduce spending on healthcare and lack of qualified professionals is dragging the market growth. However, the future growth is expected to be driven by favorable demographic factors such as growing aging population and rising incidences of road accidents and diabetes.

Expert Quote

"Europe is estimated to hold 43.12% share of the market with a value of $0.91 billion in FY 2018, growing at 9.96% in the forecast period of 2019 to 2024 and is expected to reach $1.60 billion in FY 2024. The highest growth rate of $10.83% will be witnessed by the North America region in the forecast period due to increasing adoption of advanced technologies and a greater number of companies offering products for the prosthetics and exoskeleton segment."

Scope of the Advanced Prosthetics and Exoskeletons Market

The purpose of this study is to gain a holistic view of the global advanced prosthetics and exoskeletons market in terms of various influencing factors, such as regional adoption trends, and key developments, among others. The scope of this report constitutes of an in-depth study of the market, including a thorough analysis of the products across different regions. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

Market Segmentation

The report on advanced prosthetics and exoskeletons market tracks trends, applications, targeted limbs and regional spread. These applications and targeted limb types are further segmented.

Diving further deep, this report also discusses and quantifies the various conditions responsible for amputations and disability within the limbs. The end users and regional market for the products have been described and analysed in the respective segments of the report for an in-depth understanding.

The regional and country level and markets have been sized and forecasted by considering impact of various trends. Major industry participants and their products have been thoroughly analyzed and forecasts of their performance, market share, and growth rates have been provided. The report considers 2018 as the base year and forecasts the market for the period of 2019-2024.

Key Companies in the Advanced Prosthetics and Exoskeletons Market

The key manufacturers who have been contributing significantly to the advanced prosthetics and exoskeletons market include: Bionik Laboratories, Cyberdyne, Inc., ReWalk Robotics, Ossur hf, DJO Global Inc., Rex Bionics, Alter G Inc., Breg, Inc., Bauerfiend AG, DeRoyal Industries, Inc., Ekso Bionics Holdings, Inc, Blatchford Group, Mobius Bionics, Willow Wood Global LLC , and Ottobock SE & Co. KGaA among others.

Table of Contents

Executive Summary

1. Product Definition

2. Research Scope

3. Research Methodology

  • 3.1. Advanced Prosthetics and Exoskeletons Market : Research Methodology
    • 3.1.1. Primary Data Sources
    • 3.1.2. Secondary Data Sources
    • 3.1.3. Data Triangulation
  • 3.2. Data and Prediction Modeling
  • 3.3. Market Limitations and Assumptions

4. Competitive Landscape

  • 4.1. Key Strategies and Developments
    • 4.1.1. Product Approvals and Launches
    • 4.1.2. Collaborations, Partnerships, Joint Ventures, and Agreements
    • 4.1.3. Mergers and Acquisitions
  • 4.2. Industry Insights
    • 4.2.1. Regulatory Organizations/ Associations/ Consortiums
  • 4.3. Market Share Analysis

5. Market Overview

  • 5.1. Emergence of Prosthetic- and Exoskeleton-based technologies
  • 5.2. Classification of Advanced Prosthetics and Exoskeletons Market
    • 5.2.1. Types of Prosthetics
    • 5.2.2. Types of Orthotic Exoskeletons
  • 5.3. Emerging Technologies
  • 5.4. Market Dynamics Overview
  • 5.5. Market Drivers
    • 5.5.1. Surge in Geriatric Population globally
    • 5.5.2. High Number of Amputations Due to Diabetes
    • 5.5.3. Increasing Demand for Exoskeletons Used for Rehabilitation Therapy
    • 5.5.4. Favorable Reimbursement Scenario
  • 5.6. Market Restrains
    • 5.6.1. High Cost of Advanced Prosthetics and Exoskeletons
    • 5.6.2. Stringent Government Regulations for Prosthetics and Exoskeleton
    • 5.6.3. Lack of Qualified Personnel Depriving Quality and Quantity of Services
  • 5.7. Market Opportunities
    • 5.7.1. Increasing Adoption Rate and Popularity of Prosthetics and Exoskeletons
  • 5.8. Market Trends
    • 5.8.1. Advent of 3-D Printing In Prosthetic Limbs
    • 5.8.2. Demand for High Sensitivity Within the Prosthetic Limbs
    • 5.8.3. Brain Controlled Prosthetics

6. Advanced Prosthetics and Exoskeletons Market (By Application)

  • 6.1. Market Overview
  • 6.2. Advanced Prosthetics and Exoskeletons Market, By Prosthetics
    • 6.2.1. Advanced Prosthetics and Exoskeletons Market, By Functional Application, Subsegment by Prosthetics
    • 6.2.2. Advanced Prosthetics and Exoskeletons Market, by Cosmetic Realistic Application, Subsegment by Prosthetics
  • 6.3. Advanced Prosthetics and Exoskeletons Market, by Orthotic Exoskeleton
    • 6.3.1. Advanced Prosthetics and Exoskeletons Market, By Support Application, Subsegment by Orthotic Exoskeleton
    • 6.3.2. Advanced Prosthetics and Exoskeletons Market, By Rehabilitation type, Subsegment by Orthotic Exoskeleton

7. Advanced Prosthetics and Exoskeletons Market by Limb Type

  • 7.1. Market Overview
  • 7.2. Advanced Prosthetics and Exoskeletons Market, by Lower Limb Segment
    • 7.2.1. Advanced Prosthetics and Exoskeletons Market by Transtibial Amputation, Subsegment By Lower Limb
    • 7.2.2. Advanced Prosthetics and Exoskeletons Market by Transfemoral Amputation, Subsegment By Lower Limb
  • 7.3. Advanced Prosthetics and Exoskeletons Market, by Upper Limb Segment
    • 7.3.1. Advanced Prosthetics and Exoskeletons Market by Trans-radial Amputation, Subsegment By Upper Limb
    • 7.3.2. Advanced Prosthetics and Exoskeletons Market by Trans-humeral Amputation, Subsegment By Upper Limb
  • 7.4. Advanced Prosthetics and Exoskeletons Market, By Full Body Segment

8. Advanced Prosthetics and Exoskeletons Market (By End User)

  • 8.1. Market Overview
  • 8.2. Advanced Prosthetics and Exoskeletons Market, By Orthotic and Prosthetic Clinic Segment
  • 8.3. Advanced Prosthetics and Exoskeletons Market, By Hospital Segment

9. Advanced Prosthetics and Exoskeletons Market (By Region)

  • 9.1. Market Overview
  • 9.2. North America Advanced Prosthetics and Exoskeletons Market
    • 9.2.1. North America Advanced Prosthetics and Exoskeletons Market, 2018-2024, $Million
    • 9.2.2. North America Advanced Prosthetics and Exoskeletons Market by Application, 2018-2024, $Million
    • 9.2.3. North America Advanced Prosthetics and Exoskeletons Market by Limb Type, 2018-2024, $Billion
    • 9.2.4. North America Advanced Prosthetics and Exoskeletons Market by End User, 2018-2024, $Billion
    • 9.2.5. U.S. Advanced Prosthetics and Exoskeletons Market
    • 9.2.6. Canada Advanced Prosthetics and Exoskeletons Market
  • 9.3. Europe Advanced Prosthetics and Exoskeletons Market
    • 9.3.1. Europe Advanced Prosthetics and Exoskeletons Market
    • 9.3.2. Europe Advanced Prosthetics and Exoskeletons Market (by Application)
    • 9.3.3. Europe Advanced Prosthetics and Exoskeletons Market by Limb Type
    • 9.3.4. Europe Advanced Prosthetics and Exoskeletons Market, by End User
    • 9.3.5. Germany Advanced Prosthetics and Exoskeletons Market
    • 9.3.6. U.K. Advanced Prosthetics and Exoskeletons Market
    • 9.3.7. Spain Advanced Prosthetics and Exoskeletons Market
    • 9.3.8. France Advanced Prosthetics and Exoskeletons Market
    • 9.3.9. Rest-of-Europe Advanced Prosthetics and Exoskeletons Market
  • 9.4. Asia-Pacific Advanced Prosthetics and Exoskeletons Market
    • 9.4.1 Asia-Pacific Advanced Prosthetics and Exoskeletons Market
    • 9.4.2. Asia-Pacific Advanced Prosthetics and Exoskeletons Market (by Application), 2018-2024, $Billion
    • 9.4.3. Asia-Pacific Advanced Prosthetics and Exoskeletons Market by Limb Type, 2018-2024, $Billion
    • 9.4.4. Asia-Pacific Advanced Prosthetics and Exoskeletons Market by End User, 2018-2024, $Billion
    • 9.4.5. China Advanced Prosthetics and Exoskeletons Market
    • 9.4.6. Japan Advanced Prosthetics and Exoskeletons Market
    • 9.4.7. India Advanced Prosthetic and Exoskeletons Market
    • 9.4.8. South Korea Advanced Prosthetics and Exoskeletons Market
    • 9.4.9. Rest-of-Asia-Pacific Advanced Prosthetics and Exoskeletons Market
  • 9.5. Rest-of-the-World Advanced Prosthetics and Exoskeletons Market
    • 9.5.1. Rest-of-the-World Advanced Prosthetics and Exoskeletons Market, 2018-2024, $Billion
    • 9.5.2. LATAM Advanced Prosthetics and Exoskeletons Market
    • 9.5.3. MEA Advanced Prosthetics and Exoskeletons Market

10. Company Profiles

  • 10.1. AlterG, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Role of AlterG, Inc. In the Advanced Prosthetics and Exoskeletons Market
    • 10.1.3. Key Developments
    • 10.1.4. SWOT Analysis
  • 10.2. Bionik Laboratories Corp.
    • 10.2.1. Company Overview
    • 10.2.2. Role of Bionik Laboratories Corp. in the Advanced Prosthetics and Exoskeletons Market
    • 10.2.3. Key Developments
    • 10.2.4. Financials
    • 10.2.5. Key Insights about Financial Health of the Company
    • 10.2.6. SWOT Analysis
  • 10.3. Breg, Inc
    • 10.3.1. Company Overview
    • 10.3.2. Role of Breg, Inc. in the Advanced Prosthetics and Exoskeletons Market
    • 10.3.3. Key Development
    • 10.3.4. SWOT Analysis
  • 10.4. Bauerfeind AG
    • 10.4.1. Company Overview
    • 10.4.2. Role of Bauerfeind AG in the Advanced Prosthetics and Exoskeletons Market
    • 10.4.3. Key Developments
    • 10.4.4. SWOT Analysis
  • 10.5. Blatchford Group
    • 10.5.1. Company overview
    • 10.5.2. Role of Blatchford Group in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.5.3. Key Developments
    • 10.5.4. SWOT Analysis
  • 10.6. Cyberdyne, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Role of Cyberdyne, Inc. in the Advanced Prosthetics and Exoskeletons Market
    • 10.6.3. Key Developments
    • 10.6.4. Financials
    • 10.6.5. SWOT Analysis
  • 10.7. DJO Global Inc.
    • 10.7.1. Company overview
    • 10.7.2. Role of DJO Global Inc. in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.7.3. Financials
    • 10.7.4. SWOT Analysis
  • 10.8. DeRoyal Industries, Inc
    • 10.8.1. Company Overview
    • 10.8.2. Role of DeRoyal Industries, Inc. in the Advanced Prosthetics and Exoskeletons Market
    • 10.8.3. Key Development
    • 10.8.4. SWOT Analysis
  • 10.9. Ekso Bionics Holdings, Inc.
    • 10.9.1. Company overview
    • 10.9.2. Role of Ekso Bionics Holdings, Inc. in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.9.3. Key Developments
    • 10.9.4. Financials
    • 10.9.5. SWOT Analysis
  • 10.10 Ossur hf.
    • 10.10.1. Company overview
    • 10.10.2. Role of Ossur hf. In the Global Advanced Prosthetics and Exoskeletons Market
    • 10.10.3. Key Developments
    • 10.10.4. Financials
      • 10.10.4.1. Key Insights on the Financial Health of the Company
    • 10.10.5. SWOT Analysis
  • 10.11 Ottobock SE & Co. KGaA.
    • 10.11.1. Company overview
    • 10.11.2. Role of Ottobock SE & Co. KGA in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.11.3. Key Development
    • 10.11.4. SWOT Analysis
  • 10.12 Mobius Bionics
    • 10.12.1. Company overview
    • 10.12.2. Role of Mobius Bionics in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.12.3. Key Developments
    • 10.12.4. SWOT Analysis
  • 10.13 ReWalk Robotics, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Role of ReWalk Robotics, Inc. in the Advanced Prosthetics and Exoskeletons Market
    • 10.13.3. Key Developments
    • 10.13.4. Financials
    • 10.13.5. Key Insights about Financial Health of the Company
    • 10.13.6. SWOT Analysis
  • 10.14 Rex Bionics
    • 10.14.1. Company overview
    • 10.14.2. Role of Rex Bionics in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.14.3. Key Development
    • 10.14.4. SWOT Analysis
  • 10.15 Willow Wood Global LLC.
    • 10.15.1. Company overview
    • 10.15.2. Role of Willow Wood Global LLC in the Global Advanced Prosthetics and Exoskeletons Market
    • 10.15.3. SWOT Analysis
Back to Top